• OMIGAPIL chembl:CHEMBL1232111

    Alternate Names:

    OMIGAPIL

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antiparkinson agent,for treatment of amyotrophic lateral sclerosis (ALS)
    (0 More Sources)

    Publications:

  • Interaction Score: 30.91

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name omigapil, SNT-317
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 4.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name omigapil, SNT-317
    Novel drug target Novel Target

    PMIDs:
    None found


    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiparkinson agent,for treatment of amyotrophic lateral sclerosis (ALS)
    Drug Class small molecule
    FDA Approval not approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D06KSV TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: